The FDA granted full approval to Leqembi (lecanemab) July 6, six months after handing Eisai and Biogen's Alzheimer's drug an accelerated approval. 

Keck Medicine of USC, based in Los Angeles, promoted Krist Azizian, PharmD, to fill the systemwide role of chief pharmacy officer. 

In a phase 3 trial, an investigational cancer drug from AstraZeneca and Daiichi Sankyo did not improve overall survival rates, and some patients died during the study, the organizations said July 3. 

Astellas Pharma US will stop distributing Xtandi, a prostate cancer drug that costs about $160,000 each year, to 340B contract pharmacies on Sept. 1, according to a letter obtained by 340B Health. 

The FDA has rejected Amneal Pharmaceuticals' new drug application for IPX203, which the company hoped would be approved for treatment of Parkinson's disease.

Three pharmacy TUG robots will debut at Lebanon, N.H.-based Dartmouth Health's Hitchcock Medical Center this summer.

The FDA approved the first gene therapy treatment for adults with severe hemophilia A.

Leiters, an FDA registered provider of sterile pharmacy services based in Englewood, Colo., announced the company's rebranding to Leiters Health to focus on expanding in the healthcare market.

Insilico Medicine, a biotech company based in Hong Kong, created the first drug generated entirely by artificial intelligence to successfully reach clinical testing on humans, CNBC reported June 29.

BioMarin Pharmaceutical attained the first FDA approval for a gene therapy indicated to treat severe hemophilia A.